We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.33%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$107B
AUM Growth
-$4.74B
Cap. Flow
-$4.5B
Cap. Flow %
-4.19%
Top 10 Hldgs %
16.64%
Holding
4,289
New
314
Increased
1,937
Reduced
1,469
Closed
342

Sector Composition

Rank Sector Weight
1 Technology 12.27%
2 Financials 11.39%
3 Healthcare 9.26%
4 Consumer Discretionary 6.73%
5 Industrials 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NNA
3776
DELISTED
Navios Maritime Acquisition Corporation
NNA
$26K ﹤0.01%
2,051
+460
+29% +$6.06K
GEN
3777
DELISTED
Genesis Healthcare, Inc.
GEN
$26K ﹤0.01%
17,028
+3,938
+30% +$4.61K
YTEN
3778
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$24K ﹤0.01%
+13
New +$22K
ARAV
3779
DELISTED
Aravive, Inc. Common Stock
ARAV
$20K ﹤0.01%
+2,034
New +$22.9K
MTNB icon
3780
Matinas BioPharma
MTNB
$1.88M
$19K ﹤0.01%
484
+112
+30% +$5.92K
PSHG icon
3781
Performance Shipping
PSHG
$21.6M
$17K ﹤0.01%
+76
New +$29K
EPE
3782
DELISTED
EP Energy Corporation
EPE
$17K ﹤0.01%
13,133
-2,100
-14% -$4.05K
AST
3783
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$16K ﹤0.01%
+11,049
New +$23.1K
PQ
3784
DELISTED
Petroquest Energy Inc Wd
PQ
$15K ﹤0.01%
+26,537
New +$38.8K
GPL
3785
DELISTED
Great Panther Mining Limited
GPL
$14K ﹤0.01%
1,184
HURA
3786
TuHURA Biosciences
HURA
$138M
$13K ﹤0.01%
1
TMBR
3787
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$12K ﹤0.01%
+3
New +$8.89K
IDXG
3788
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$11K ﹤0.01%
1,300
IMNP
3789
DELISTED
Immune Pharmaceuticals Inc.
IMNP
$11K ﹤0.01%
33,399
+9,895
+42% +$4.71K
CXRX
3790
DELISTED
Concordia International Corp. Common Stock
CXRX
$11K ﹤0.01%
21,709
+2,000
+10% +$1.31K
MBAI
3791
Check-Cap
MBAI
$8.19M
$10K ﹤0.01%
78
KPRX icon
3792
Kiora Pharmaceuticals
KPRX
$11.3M
$10K ﹤0.01%
5
+1
+25% +$4.32K
ORKA
3793
Oruka Therapeutics
ORKA
$5.82B
$10K ﹤0.01%
+93
New +$25K
ESNC
3794
DELISTED
EnSync Inc
ESNC
$10K ﹤0.01%
+26,591
New +$10.6K
RSYS
3795
DELISTED
Radisys Corp
RSYS
$9K ﹤0.01%
13,951
+2,513
+22% +$2.25K
GCVRZ
3796
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$8K ﹤0.01%
16,888
SEEL
3797
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
RAS
3798
DELISTED
RAIT Financial Trust
RAS
$5K ﹤0.01%
34,232
+7,590
+28% +$2.78K
ABBV icon
3799
CALL
AbbVie
ABBV
$443B
-50,000
Closed -$4.84M
ABBV icon
3800
PUT
AbbVie
ABBV
$443B
-225,000
Closed -$21.8M

Similar funds

Credit Suisse's Q1 2018 Portfolio in Review

As of Q1 2018, Credit Suisse held 4,289 positions worth $107B, down 4.2% from $112B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse withdrew a net $4.5B in Q1 2018, closing 342 positions and reducing 1,469 holdings. Its most notable exit was VelocityShares Daily Inverse VIX Short Term ETN, an estimated $959M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Credit Suisse opened a new position in Cambria Shareholder Yield ETF worth $75.4M.

  • Credit Suisse's largest Q1 2018 buy was Cambria Shareholder Yield ETF: 2,000,000 shares worth $75.4M.
  • Credit Suisse added most to iShares Core S&P Mid-Cap ETF in Q1 2018, an estimated $731M increase.
  • Credit Suisse's biggest Q1 2018 reduction was UnitedHealth, cutting an estimated $1.54B.
  • Credit Suisse fully exited VelocityShares Daily Inverse VIX Short Term ETN in Q1 2018, selling an estimated $959M.
  • Credit Suisse's ten largest holdings make up 17% of its $107B portfolio in Q1 2018.
  • Credit Suisse opened 314 new positions and closed 342 in Q1 2018.
  • Credit Suisse's portfolio value fell 4.2% quarter-over-quarter to $107B.

Based on Credit Suisse's 13F filing for Q1 2018, filed 15 May 2018.